Immunocytochemical studies on the distribution pattern of daunomycin in rat gastrointestinal tract

Histochemistry and Cell Biology

Volumn 128, Issue 3, 2007, Pages 285-290

  Ohara, Koji ^a   Shin, Masashi ^a   Nakamuta, Hiromichi ^b   Larsson, Lars Inge ^d   Hougaard, David M ^c   Fujiwara, Kunio ^a  

^a SOJO UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Apoptosis; Daunomycin; Distribution; Gastrointestinal tract; Immunocytochemistry; Monoclonal antibody; Rat

Indexed keywords

DAUNORUBICIN;

ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; ENDOTHELIUM CELL; GASTROINTESTINAL TRACT; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LARGE INTESTINE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SMOOTH MUSCLE FIBER; STOMACH;

ANIMALS; APOPTOSIS; DAUNORUBICIN; GASTROINTESTINAL TRACT; IMMUNOHISTOCHEMISTRY; RATS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

RATTUS;

EID: 34548163297     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-007-0314-6     Document Type: Article

References (37)

1. Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29:775
2. Anikumar TV, Sarraf CE, Hunt T, Alison MR (1992) The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br J Cancer 65:552-558
3. Bittl A, Nap M, Jager W, Cornillie F, Lang N (1995) Immunohistochemical detection of P-glycoprotein on frozen and paraffin-embedded tissue sections of normal and malignant tissues. Anticancer Res 15(3):1007-1014
4. Blum RH, Carter SK (1974) Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 80:249-259
5. Bristow MR (1982) Toxic cardiomyopathy due to doxorubicin. Hosp Pract 18:291-300
6. Burke JF, Laucius JF, Brodovsky HS, Soriano RZ (1977) Doxorubicin hydrochloride-associated renal failure. Arch Intern Med 137:385-388
7. Chabner BA, Ryan DP, Paz-Ares L, Carbonero RG, Calabresi P (2001) Antineoplastic agents. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 1389
8. Cherrington NJ, Hartley DP, Li N, Johnson DR, Klaassen CD (2002) Organ distribution of multidrug resistance protein 1, 2, and 3 (Mep 1,2, and 3) mRNA and hepatic induction of Mrp 3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300:97-104
9. Damavandi E, Hishikawa Y, Izumi S, Shin M, Koji T (2002) Involvement of Bax redistribution in the induction of germ cell apoptosis in neonatal mouse testis. Acta Histochem Cytochem 35:449-459
10. Dimarco A, Gaetani M, Dorigotti L, Soldati M, Bellini O (1963) Experimental studies of the antineoplastic activity of a new antibiotic daunomycin. Tumori 49:203-217
11. DuBuske LM (2005) The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions. Drug Saf 28:789-801
12. Egorin MJ, Hildebrand RC, Cimino EF, Bachur NR (1974) Cytofluorescence localization of adriamycin and daunorubicin. Cancer Res 34:2243-2245
13. Ernest S, Bello-Reuss E (1995) Expression and function of P-glycoprotein in mouse kidney cell line. Am J Physiol 269:C323-C333
14. Fujiwara K, Takatsu H, Tsukamoto K (2005) Immunocytochemistry for drugs containing an aliphatic amino group in the molecule, anticancer antibiotic daunomycin as a model. J Histochem Cytochem 53:467-474
15. Fujiwara K, Shin M, Hougaard MH, Larsson LI (2007) Distribution of anticancer antibiotic daunomycin in the rat heart an kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem Cell Biol 127:69-77
16. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
17. Graham RC, Karnovsky MJ (1966) glomerular permeability. Ultrastructural cytochemitry by a new technique. J Histochem Cytochem 14:291-302
18. Hussain I, Kellett L, Affleck J, Shepherd J, Boyd R (2002) Expression and cellular distribution during development of the peptide transporter (PepT1) in the small intestinal epithelium of the rat. Cell Tissue Res 307(1):139-142
19. Ijiri K, Potten CS (1987) Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 55:113-123
20. Katsura T, Inui K (2003) Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. Drug Metab Pharmacokinet 18(1):1-15
21. Leu BL, Huang JD (1995) Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother Pharmacol 35:432-436
22. Ohara K, Shin M, Larsson LI, Fujiwara K (2007) Improved immunocytochemical detection of daunomycin. Histochem Cell Biol 127(6):603-608
23. Pan Y, Wong EA, Bloomquist JR, Webb KE Jr (2001) Expression of a cloned ovine gastrointestinal peptide transporter (oPepT1) in Xenopus oocytes induces uptake of oligopeptides in vitro. J Nutr 131(4):1264-1270
24. Paschoud N, Bignell C, Reinhold HS (1985) A double fluorescence method for detecting doxorubicin distribution and vascular supply in the mouse kidney. J Histochem Cytochem 33:73-76
25. Platel D, Bonorone-Adele S, Robert J (2001) role of daunorubicinol in daunomycin-induced cardiotoxicity as evaluated with the model of isolated perfused rat heart. Pharmacol toxicol 88:250-254
26. Rutherford A, Willingtham MC (1993) Ultrastructural localization of daunomycin in multidrug-resistant culture cells with modulation of the multidrug transpoter. J Histochem Cytochem 41:1573-1577
27. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033
28. Takahashi S, Bachur NR (1975) Daunorubicin metabolites in human urine. J Pharmacol Exp Ther 195:41-49
29. Tanigawara Y (2000) Role of P-glycoprotein in drug disposition. The Drug Monit 22:137-140
30. Thakkar NS, Potten CS (1993) Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-D-glucose. Cancer Res 53:2057-2060
31. Thakkar NS, Potten CS (1992) Abrogation of adriamycin toxicity in vivo by cycloheximide. Biochem Pharmacol 43:1683-1691
32. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738
33. Tsuji A (2006) Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy. J Infect Chemother 12:241-250
34. van Asperen J, van Tellingen O, van der Valk MA, Rozenhart M, Beijnen JH (1998) Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A. Clin Cancer Res 4:2293-2297
35. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and sensitive KB cells: Effects of verapamil and other drugs. Cancer Res 46:5941-5946
36. Zagotto G, Gatto B, Moro S, Sissi C, palumbo M (2001) Anthracyclines: recent developments in their separation and quantification. J Chromatogr B Biomed Sci Appl 764:161-171
37. Zhang J, Clark JR, Herman EH, Ferrans VJ (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931-1943